Yan-Ruide

Yan-Ruide Li received a bachelor degree at Zhejiang University and a Ph.D. degree at UCLA. Currently, Yan-Ruide works as a postdoctoral scholar at UCLA focusing on the genetic engineering of invariant natural killer T (iNKT) cells for the treatment of cancer including solid tumors and hematologic malignancies. During his research, a multitude of strategies are used, including providing the immune cells with tumor-recognition specificity, as well as enhancing their tumor-fighting capacity. Yan-Ruide is also leading several promising projects aiming to generate allogeneic hematopoietic stem cell-derived chimeric antigen receptor-engineered iNKT cells for off-the-shelf cancer immunotherapy.